BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

CUSIP: 090572207

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
19,395,139
Share change
-137,132
Total reported value
$5,876,802,288
Put/Call ratio
11%
Price per share
$302.99
Number of holders
393
Value change
-$33,433,698
Number of buys
149
Number of sells
198

Quarterly Holders Quick Answers

What is CUSIP 090572207?
CUSIP 090572207 identifies BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alice N. Schwartz
3/4/5 13D/G
Director Emeritus, 10%+ Owner
12%
from 13D/G
11,862,229
mixed-class rows
$3,592,267,092 26 Aug 2024
Steven D. Schwartz
3/4/5
10%+ Owner
mixed-class rows
8,560,438
mixed-class rows
$2,584,683,847 26 Aug 2024
Norman D. Schwartz
13D/G 3/4/5
Chairman & CEO, Director, 10%+ Owner
97%
4,929,036
$1,382,052,897 $0 25 Sep 2025
First Eagle Investment Management, LLC
13F 13D/G
Company
11%
from 13D/G
2,520,319
$706,672,287 30 Sep 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group - 23-1945930
8.4%
from 13D/G
1,793,537
$502,889,839 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
7.4%
from 13D/G
1,695,849
$475,499,107 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP
13F
Company
21%
1,062,938
$298,018,552 30 Sep 2025
13F
Veritas Asset Management LLP
13F
Company
17%
844,039
$236,660,095 30 Sep 2025
13F
ARIEL INVESTMENTS, LLC
13F
Company
16%
809,480
$226,970,097 30 Sep 2025
13F
EARNEST PARTNERS LLC
13F
Company
12%
609,284
$170,837,141 30 Sep 2025
13F
STATE STREET CORP
13F
Company
11%
571,599
$160,270,644 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
9.1%
459,887
$128,947,715 30 Sep 2025
13F
Capital Research Global Investors
13F
Company
8.2%
418,355
$117,302,558 30 Sep 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
7.8%
397,171
$111,362,776 30 Sep 2025
13F
First Pacific Advisors, LP
13F
Company
7.8%
394,414
$110,589,741 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.9%
350,216
$98,213,875 30 Sep 2025
13F
PARNASSUS INVESTMENTS, LLC
13F
Company
6.2%
315,328
$88,414,818 30 Sep 2025
13F
SEI INVESTMENTS CO
13F
Company
5.6%
282,469
$79,199,024 30 Sep 2025
13F
Mawer Investment Management Ltd.
13F
Company
4.8%
243,468
$68,265,993 30 Sep 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
4.7%
237,903
$66,705,645 30 Sep 2025
13F
SOUTHEASTERN ASSET MANAGEMENT INC/TN/
13F
Company
4.7%
237,254
$66,523,650 30 Sep 2025
13F
UBS Group AG
13F
Company
4.5%
230,719
$64,691,300 30 Sep 2025
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
4.5%
226,070
$63,387,767 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
4.5%
226,006
$63,369,823 30 Sep 2025
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
4.3%
217,596
$61,012,000 30 Sep 2025
13F
GW&K Investment Management, LLC
13F
Company
3.6%
183,845
$51,550,000 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.5%
179,966
$50,460,667 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
3.5%
176,091
$49,374,000 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
mixed-class rows
174,774
mixed-class rows
$49,000,977 30 Sep 2025
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
3.1%
155,524
$43,607,374 30 Sep 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
2.7%
134,767
$40,153,827 30 Sep 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.7%
138,889
$38,934,000 30 Sep 2025
13F
Fisher Asset Management, LLC
13F
Company
2.6%
133,465
$37,422,250 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
2.6%
133,213
$37,351,502 30 Sep 2025
13F
MANGROVE PARTNERS IM, LLC
13F
Company
2.5%
126,853
$35,568,313 30 Sep 2025
13F
QVIDTVM Management LLC
13F
Company
2.5%
126,480
$35,463,727 30 Sep 2025
13F
FEDERATED HERMES, INC.
13F
Company
2.5%
126,137
$35,367,553 30 Sep 2025
13F
Gotham Asset Management, LLC
13F
Company
2.5%
124,626
$34,943,884 30 Sep 2025
13F
FRANKLIN RESOURCES INC
13F
Company
2.7%
134,927
$34,492,519 30 Sep 2025
13F
Tikvah Management LLC
13F
Company
2.2%
111,084
$31,146,843 30 Sep 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
2.1%
107,753
$30,212,941 30 Sep 2025
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
2.1%
107,299
$30,085,567 30 Sep 2025
13F
Hound Partners, LLC
13F
Company
2.1%
103,963
$29,150,186 30 Sep 2025
13F
Ilex Capital Partners (UK) LLP
13F
Company
2%
100,558
$28,195,458 30 Sep 2025
13F
Boston Trust Walden Corp
13F
Company
1.9%
95,448
$26,762,665 30 Sep 2025
13F
JNE Partners LLP
13F
Company
1.8%
92,100
$25,823,919 30 Sep 2025
13F
Artisan Partners Limited Partnership
13F
Company
1.7%
86,371
$24,217,565 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.5%
75,477
$21,164,000 30 Sep 2025
13F
Allianz Asset Management GmbH
13F
Company
1.3%
66,549
$18,659,674 30 Sep 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
1.3%
65,230
$18,290,000 30 Sep 2025
13F

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2025

As of 31 Dec 2025, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 393 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,395,139 shares. The largest 10 holders included First Eagle Investment Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, STATE STREET CORP, Veritas Asset Management LLP, Capital Research Global Investors, and BANK OF AMERICA CORP /DE/. This page lists 393 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
392
Q4 2025 holders
393
Holder diff
1
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .